Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

donepezil

Known as: DONEP, Donepezilum, donepezil [Chemical/Ingredient] 
The hydrochloride salt of a piperidine derivative with neurocognitive-enhancing activity. Donepezil reversibly inhibits acetylcholinesterase, thereby… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
BACKGROUND Clinical trials have shown the benefits of cholinesterase inhibitors for the treatment of mild-to-moderate Alzheimer's… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
Review
2006
Review
2006
BACKGROUND Alzheimer's disease is the most common cause of dementia in older people. One of the aims of therapy is to inhibit the… Expand
Highly Cited
2005
Highly Cited
2005
BACKGROUND Mild cognitive impairment is a transitional state between the cognitive changes of normal aging and early Alzheimer's… Expand
  • table 1
  • figure 1
  • table 2
  • table 2
  • table 3
Highly Cited
2004
Highly Cited
2004
CONTEXT Memantine is a low- to moderate-affinity, uncompetitive N-methyl-D-aspartate receptor antagonist. Controlled trials have… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Highly Cited
2004
Highly Cited
2004
BACKGROUND Cholinesterase inhibitors produce small improvements in cognitive and global assessments in Alzheimer's disease. We… Expand
Highly Cited
2002
Highly Cited
2002
  • D. Deleu
  • Neurology
  • 2002
  • Corpus ID: 43694859
To the Editor: In their recently published, 1-year prospective, double blind, placebo-controlled study, Winblad et al.1 examined… Expand
Highly Cited
2001
Highly Cited
2001
Objective: To investigate the efficacy and safety of donepezil in patients with moderate to severe AD (standardized Mini-Mental… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 4
Highly Cited
2001
Highly Cited
2001
Objective: To examine the effects of donepezil compared with placebo on the preservation of function in patients with AD over a 1… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Highly Cited
1999
Highly Cited
1999
Donepezil has been shown to be well tolerated and to improve cognition and global function in patients with mild to moderately… Expand
  • table 1
  • figure 2
  • figure 4
  • table 2
  • table 3
Highly Cited
1998
Highly Cited
1998
The efficacy and safety of donepezil as a treatment for patients with mild to moderate Alzheimer's disease (AD) was investigated… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 4